HRH3 and neurodegenerative disease: In conclusion, our research confirmed that hybrid chalcones are a promising starting scaffold for DTLs, as H3R antagonists, and MAO-B inhibitors, with potential utility not only in neurodegenerative diseases but also in anticancer therapy.